Directly Observed Therapy (DOT) Strategy in Tuberculosis

1. Introduction & Historical Context

2. Definition of DOT

"DOT, the practice of observing the patient swallow the antituberculosis medications, has been widely used as the standard of practice in many programs." — Murray & Nadel's Textbook of Respiratory Medicine

3. Rationale / Why DOT is Necessary

4. The Five Elements / Components of the DOTS Strategy (WHO)

5. DOT in Practice: How It Works

a. Treatment Supporter

• A health care worker (nurse, ASHA, community health worker)
• A community volunteer
• A family member (in some programs)

b. Location of DOT

• Health facility-based DOT — patient visits clinic daily
• Community/home-based DOT — health worker visits patient
• Workplace/school-based DOT — for employed/student patients
• Video-observed therapy (VOT/VDOT) — via smartphone app or video call; a randomized controlled superiority trial showed similar outcomes to in-person DOT, with the advantage of being less resource-intensive

c. Dosing Schedule Under DOT

• Preferred: 7 days/week throughout both intensive and continuation phases (supported by recent RCT evidence)
• Alternative: 3×/week in continuation phase only — carries slightly higher relapse risk but acceptable in resource-limited settings where daily DOT is impossible (must be DOT-administered)

6. Standard Treatment Regimen Under DOT

Drug-Susceptible TB (Adults)

• Total duration: 6 months
• A newer 4-month regimen (2HPMZ/2HPM: isoniazid, pyrazinamide, rifapentine, moxifloxacin) is now WHO and CDC-recommended as an alternative for age ≥12 years
• Pyridoxine (10–25 mg/day) must be co-administered in high-risk patients to prevent INH-induced neuropathy

Regimens Mandatorily Under DOT

7. Patient-Centered Care in DOT

• A case manager is assigned to each patient at the start of treatment
• A comprehensive, individualized case management plan is developed jointly by the patient and case manager
• Barriers to adherence are actively identified and addressed:
  • Patient-related barriers: lack of belief in illness severity, substance abuse, social stigma, poverty, homelessness, joblessness
  • Provider-related barriers: lack of support/education, inconvenient clinic hours

Supportive Interventions Alongside DOT:

1. Educational/counseling support — seriousness of disease, importance of adherence
2. Psychological support — counseling, peer-group support (especially for stigma)
3. Material support — food baskets, transport subsidies, financial incentives, housing support (proven to reduce indirect costs and mortality; e.g., RATIONS trial in India showed nutritional support reduced TB mortality significantly)
4. Accessible health services — suitable location, responsive schedules, phone/video communication channels

8. Advantages of DOT

"DOT is associated with improved treatment success and decreased time-to-sputum smear conversion." — Murray & Nadel's Textbook of Respiratory Medicine

9. DOT vs. Self-Administered Therapy (SAT)

10. Video DOT (VDOT / Digital DOT)

• Patient records themselves taking medication via smartphone app
• Health worker reviews the video
• A multicenter, randomized, controlled superiority trial comparing VOT (smartphone app) vs. in-person DOT showed similar treatment outcomes
• Less resource-intensive; preserves patient privacy
• Particularly useful for patients with demonstrated good adherence on traditional DOT
• Decisions must be made jointly with the patient (privacy, access to technology)

11. DOTS in India: Revised National TB Control Programme (RNTCP) / National TB Elimination Programme (NTEP)

• Treatment regimens are weight-based, given in fixed-dose combinations (FDCs)
• DOT provider — any trained individual acceptable to patient and accountable to health system
• Nikshay — IT-based case management system for notification, tracking, and outcome reporting
• Nikshay Poshan Yojana — direct benefit transfer of ₹500/month to TB patients for nutritional support (material support component)
• NTEP Target: 90% treatment success rate; 90% case notification

12. Challenges and Limitations of DOT

1. Resource-intensive — requires dedicated health workers, infrastructure
2. Stigmatizing — daily clinic visits can expose patients to social stigma
3. Inconvenient — geographic and time barriers (especially in rural areas)
4. Privacy concerns — must balance supervision with patient rights
5. Evidence debate — some systematic reviews question DOT superiority over SAT in all settings; the benefit may be highest in high-risk, socially vulnerable populations
6. Default during inconvenience — if DOT is not patient-centered, patients may default entirely

13. Monitoring and Evaluation Under DOTS

14. Beyond DOTS: The End TB Strategy

1. Integrated, patient-centered care and prevention (includes DOT, social support)
2. Bold policies and supportive systems (UHC, social protection)
3. Intensified research and innovation (new drugs, diagnostics, vaccines)

Summary Points for Exam

• DOT = observing every dose being swallowed by a trained person
• DOTS = 5-component WHO strategy (political commitment, case detection, standardized Rx, drug supply, monitoring)
• DOT improves treatment success and smear conversion but not mortality compared to SAT
• Daily DOT (7 days/week) preferred; intermittent DOT (3×/week) only in continuation phase
• VDOT is non-inferior to in-person DOT (RCT evidence)
• Patient-centered care is the backbone: address educational, psychological, and material barriers
• India: NTEP, Nikshay, Nikshay Poshan Yojana
• World Bank: DOTS declared most cost-effective health intervention ever deployed
• By 2020: 60 million lives saved through DOTS